4.4 Article

Development of Low Cost Rapid Fabrication of Sharp Polymer Microneedles for In Vivo Glucose Biosensing Applications

Journal

ECS JOURNAL OF SOLID STATE SCIENCE AND TECHNOLOGY
Volume 4, Issue 10, Pages S3053-S3058

Publisher

ELECTROCHEMICAL SOC INC
DOI: 10.1149/2.0141510jss

Keywords

-

Funding

  1. Science Foundation Ireland under Research Frontiers Program [SFI/09/RFP/CAP2455]
  2. Science Foundation Ireland and Enterprise Ireland under the Technology Innovation Development Award NASCENCE [12/TIDA/I2377]
  3. Enterprise Ireland under Commercialisation Fund [CF-2012-2339]
  4. European Commission under FP7 Security project CommonSense [261809]
  5. Irish Higher Education Authority PRTLI programs (Cycle 3 Nanoscience)
  6. Irish Higher Education Authority PRTLI programs (Cycle 4 INSPIRE)
  7. Science Foundation Ireland (SFI) [12/TIDA/I2377] Funding Source: Science Foundation Ireland (SFI)

Ask authors/readers for more resources

New approaches to enable more effective management of diabetes mellitus, such as continuous glucose monitoring are being developed both to prevent unstable episodes of hypo or hyper glycaemia and also to provide an improved user experience. One emerging approach to realize these requirements is to fabricate a minimally invasive transdermal sensor for the direct in vivo detection of glucose in the interstitial fluid. Microneedles - sharp, microscopic structures measuring less than 1 mm in length - have been previously employed to allow painless penetration of the stratum corneum for delivery of drugs and vaccines. In this work we present, ultra sharp gold coated polymer microneedle arrays (sub micron tip radii) which are fabricated using a low cost polymer replication approach. Critical dimensions of the microneedle arrays are characterized using a combination of optical and scanning electron microscopies. Fabricated microneedle devices are characterized by cyclic voltammetry to explore functionality. The voltammetric detection of glucose is performed using ferrocene monocarboxylic acid as an oxidising mediator in the presence of glucose oxidase. The biosensor can be applied to the quantification of glucose in the physiological range (2 - 13.5 mM). The sensors demonstrate high selectivity towards glucose with negligible interference from other oxidizable species including uric acid, ascorbic acid, mannose, fructose, salicylic acid (Aspirin) and acetaminophen (Paracetamol). This demonstrates potential future use of these microneedle devices for in vivo glucose detection. (C) The Author(s) 2015. Published by ECS. This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives 4.0 License (CC BY-NC-ND, http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is not changed in any way and is properly cited. For permission for commercial reuse, please email: oa@electrochem.org. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available